About
ATI develops innovative medical devices for the ophthalmological market, which dramatically improve the patient’s experience during diagnostic procedures, while increasing their efficiency. ATI’s flagship product, FIM (Field Induced Mydriasis) is the world’s first pupil dilation device. The device dramatically improves the examination experience, by achieving full dilation within 90-120 seconds and full recovery within minutes. FIM is a safe non-contact and drug-free device. ATI is currently developing an innovative personal ocular tonometer, called NIT. This device will be used by the patients themselves to measure their intraocular pressure for early detection of Glaucoma.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 22 investors are based in Ra'anana, HaMerkaz, Israel.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech hardware
- Location
- Ra'anana, Israel
Contact Information
Find more investors like Advanced
Search Investors